The latest Government Bioscience Grants (GBG) report from G2G Consulting identifies 78 non-dilutive funding opportunities across critical biotech research areas.
Key Opportunities
Combat Medicine: DARPA’s MASH program seeks autonomous technologies for finding and stabilizing internal bleeding in forward medical facilities.
Infectious Disease: BARDA’s Project BioShield offers substantial funding for Marburg and Sudan virus vaccine development and procurement.
Rare Diseases: Multiple FDA and PCORI opportunities support natural history studies, clinical trials, and patient-centered research for underserved conditions.
Women’s Health: Military Family Health Research Award provides up to $3 million for menopause research, sex-specific healthcare, and addressing barriers to family formation.
Agriculture: USDA NIFA grants support research across six priority areas with funding up to $10 million.
Ongoing Access
The CHEERS program continues accepting white papers for aerospace medicine, public health, occupational medicine, and expeditionary care on a rolling basis.
Additional Intel
Key RFIs to watch:
- DARPA: Chemically and Biologically Enhanced Microsystems
- NIIMBL: mRNA-LNP Drug Product Filtration Practices
Exclusive iBIO Access
G2G will provide exclusive consultation for iBIO members during their August 21 webinar at 11:00 AM. This session offers direct access to federal funding expertise and opportunity matching.
Register for the exclusive iBIO member consultation through the member portal.